Search results for Glp-1 Agonists

GLP-1s reduced ED visits, infections and revisions in orthopedics

NEW ORLEANS — Results presented here showed GLP-1 receptor agonists may be associated with lower ED utilization and a reduction in surgical site infections and revisions for a rang...

Should gastroenterologists prescribe GLP-1s to their patients?

This month’s Healio Exclusive in Healio Gastroenterology poses a highly topical question.GLP-1 receptor agonists have revolutionized the treatment of obesity and related conditions...

Should gastroenterologists prescribe GLP-1s to their patients?

This month’s Healio Exclusive in Healio Gastroenterology poses a highly topical question.GLP-1 receptor agonists have revolutionized the treatment of obesity and related conditions...

GLP-1 agonists and the hidden power of outdoor exercise

A recent report documented something remarkable: Americans on glucagon-like peptide-1 (GLP-1) agonists are falling in love with exercise for the first time. A man who struggled to...

GLP-1 agonists and the hidden power of outdoor exercise

A recent report documented something remarkable: Americans on glucagon-like peptide-1 (GLP-1) agonists are falling in love with exercise for the first time. A man who struggled to...

GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers

WEDNESDAY, May 27, 2026 — A new study suggests GLP-1 medications may slow the spread of certain obesity-related cancers. "GLP-1 receptor agonists have never been just glucose-lower...

GLP-1s may not raise DKA, pancreatitis risk in type 1 diabetes

LAS VEGAS — GLP-1 receptor agonists may not raise the risk for diabetic ketoacidosis or pancreatitis among adults with type 1 diabetes, according to the findings from a single-cent...

GLP-1 Receptor Agonist Weight Loss Therapy and Arthroplasty: Are Women at Greater Risk for Complications?

The GLP-1 receptor agonists have profoundly revolutionized metabolic therapy. These agents have rapidly become central to obesity management, producing substantial effects on weigh...

GLP-1 Receptor Agonists and Upper Endoscopy – Guidance for Periprocedural Management

Brain-cell breakthrough supercharges GLP-1 weight loss and prevents plateaus

Scientists have identified a new way to supercharge the GLP-1 receptor agonist semaglutide, opening the door to boosting the drug's weight-loss power and helping long-term users pu...

GLP-1s sustain weight loss in IBD, obesity without worse symptoms

CHICAGO — Patients with obesity and inflammatory bowel disease showed improved bowel function while receiving GLP-1 receptor agonists and lifestyle counseling, in contrast to the g...

Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk

A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Resea...

GLP-1 drugs reduce risk of major adverse cardiovascular events

New research has shown that GLP‑1 weight-loss drugs deliver protection against heart attacks, strokes and premature death over a sustained period of time.

Best GLP-1 Drug on the Market Is Even Better Than We Knew

Doctors Reveal The Most Common Side Effects Of GLP-1s — And How To Manage Them

Ozempic, Wegovy and other GLP-1 medications are popular but can cause unwanted health concerns.

GLP-1 Drugs Offer Real Hope for People With Pain or Addiction

By Dr. Lynn WebsterIn Greek mythology, the goddess Panacea carried a potion that could heal any disease. It’s a seductive image, and it’s how GLP-1 drugs can start to feel as repor...

GLP-1s Now Linked To Lower Risk Of 4 Different Cancerous Tumors

What started as a diabetes medication has rapidly become one of the most talked-about drug categories in modern medicine. GLP-1 medications such as Ozempic, Wegovy,...

GLP-1 Drugs Target the Roots of Dementia

A comprehensive review of 30 studies finds that GLP-1 receptor agonists are effective at tackling the biological drivers of Alzheimer’s disease.

594 GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS VERSUS SLEEVE GASTRECTOMY FOR MORBID OBESITY: A TARGET TRIAL EMULATION STU...

GLP-1 use shows ‘far higher’ than expected risk for residual gastric content in endoscopy

Use of GLP-1s or glucose-dependent insulinotropic polypeptide agonists before upper endoscopy significantly increased the risk for residual gastric volume, according to data publis...

GLP-1 Weight Loss Linked To Dramatically Lower Risk of Sleep Apnea, Kidney Disease and More

New research indicates that maintaining meaningful weight loss after starting GLP-1-based therapies could play an important role in reducing the risk of multiple obesity-related di...

GLP-1 use prior to TJA yielded higher rates of malnutrition

NEW ORLEANS — Patients taking GLP-1 agonists before total joint arthroplasty experienced significantly higher rates of preoperative nutritional deficiencies, according to results p...

GLP-1 Drugs May Cut Risk of Heart Attack, Stroke, and Death by About 13 Percent

Learn how GLP-1 drugs may protect the heart by lowering inflammation, improving blood vessels, and reducing key risk factors.

GLP-1 Drugs May Improve Breast Cancer Outcomes

WEDNESDAY, May 13, 2026 — Popular GLP-1 medications may be linked to better long-term outcomes for some breast cancer patients. Previous research has shown breast cancer survivors...